2022
DOI: 10.1016/j.ygeno.2022.110466
|View full text |Cite
|
Sign up to set email alerts
|

SARS-CoV-2 VOCs, Mutational diversity and clinical outcome: Are they modulating drug efficacy by altered binding strength?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(17 citation statements)
references
References 59 publications
0
17
0
Order By: Relevance
“…Weisblum et al found that K444R/Q/N occurs after exposure to convalescent plasma [55]. Among largely diversified VOCs such as Delta, S:K444N was associated with reduced remdesivir binding and increased mortality [56].…”
Section: S:k444xmentioning
confidence: 99%
“…Weisblum et al found that K444R/Q/N occurs after exposure to convalescent plasma [55]. Among largely diversified VOCs such as Delta, S:K444N was associated with reduced remdesivir binding and increased mortality [56].…”
Section: S:k444xmentioning
confidence: 99%
“…Additionally, in previous studies, it has been shown that Q493R in the RBD spike is significantly associated with Omicron disease severity in patients. Docking studies of Remdesivir with R493 mutant viral protein demonstrated a reduction in the binding strength of Remdesivir to mutant Spike proteins [ 60 ]. As for the E484 residue mutated to A484, the E484 in the spike WT of the RBD forms contact with K31 in ACE2 WT.…”
Section: Resultsmentioning
confidence: 99%
“…The 440-position found at a loop near the binding interface [ 65 ] causes a change of charge and has been shown to massively increase the interaction energy of the RBD with ACE2 [ 60 ], as well as an increased ability to escape neutralising antibodies [ 68 ]. It is also associated with an increased mortality [ 69 ]. Mutations including Asn-to-Lys (as seen in BA.1, BA.1.1, BA.2, group 5, XBB, BJ.1, BA.2.12.1, BA.2.75.4, BA.2.75.5, BA.2.75.7, BF.7, and BQ.1.1) cause a change of charge, leading to a positively charged interface.…”
Section: Discussionmentioning
confidence: 99%
“…Mutations including Asn-to-Lys (as seen in BA.1, BA.1.1, BA.2, group 5, XBB, BJ.1, BA.2.12.1, BA.2.75.4, BA.2.75.5, BA.2.75.7, BF.7, and BQ.1.1) cause a change of charge, leading to a positively charged interface. Previous studies reported that mutation of residue K444N (BU.1, BW.1, group 5, XBB, and BJ.1) was associated with increased mortality [ 69 ]. Mutation at residue G446S shows polarity changes, although it has been shown to decrease ACE2 binding [ 59 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation